Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning ...

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

For decades, pharmaceutical marketing has been built on a simple premise: if we present the right data, to the right audience ...

All 15-year-old children in the UK should be offered the vaccine against meningitis B (MenB) in the wake of fatal outbreaks ...

Just a few months after it was formed by a merger of two psychedelic drug developers, AtaiBeckley has been snapped up by Eli ...

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval in the US, after getting the go-ahead ...

The steady stream of biotechs aiming to list on the Nasdaq has continued, with Attovia Therapeutics and Braveheart Bio the ...

The European Commission has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, making it the first oral ...

Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...

Any uncertainty about whether the second Trump administration would prioritise healthcare fraud enforcement was put to rest ...

A national newborn screening programme for spinal muscular atrophy (SMA) will be rolled out in England, to give babies the ...

Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of ...